AINostix (XAIR) - נכסים מצרפיים של הפעילות העסקית

Beyond Air, Inc. (XAIR) relies on external electronics and sensor suppliers, while independently completing the configuration of gas generators. The brand is valued by medical professionals for its effective bedside therapy methods for respiratory pathologies. This price chart of total assets, illustrating trading dynamics, captured the figure 30.50. The company is currently focusing on the expansion of the LungFit system, seeking to maximize the presence of its devices in US clinics.

Total assets, reverse-calculated via ROA, reflect the aggregate value of resources and liabilities, allowing for the filtering of temporary market noise to assess the business's actual material base. The analysis of total asset calculations serves as a portfolio stress-testing tool, as excessive base growth during the expansion of the Beyond Air, Inc. (XAIR) LungFit system in US hospitals could increase the risk of a sharp capital correction under negative scenarios.